I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 556.2 ILS -1.28% Market Closed
Market Cap: 267.5m ILS

Intrinsic Value

The intrinsic value of one INCR stock under the Base Case scenario is 1 680.11 ILS. Compared to the current market price of 556.2 ILS, InterCure Ltd is Undervalued by 67%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INCR Intrinsic Value
1 680.11 ILS
Undervaluation 67%
Intrinsic Value
Price
I
Worst Case
Base Case
Best Case

Valuation History
InterCure Ltd

INCR
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for INCR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

InterCure Ltd
TASE:INCR
IL
Pharmaceuticals
Market Cap
267.5m ILS
IPO
Jul 26, 2007
IL
Pharmaceuticals
Market Cap
267.5m ILS
IPO
Jul 26, 2007
Price
₪false
EPS
₪false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about InterCure Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
InterCure Ltd

Current Assets 418.8m
Cash & Short-Term Investments 101.3m
Receivables 201.5m
Other Current Assets 116m
Non-Current Assets 367.8m
Long-Term Investments 20.4m
PP&E 97.5m
Intangibles 221.1m
Other Non-Current Assets 28.9m
Efficiency

Free Cash Flow Analysis
InterCure Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
InterCure Ltd

Revenue
355.6m ILS
Cost of Revenue
-247.2m ILS
Gross Profit
108.3m ILS
Operating Expenses
-74.1m ILS
Operating Income
34.3m ILS
Other Expenses
-96.2m ILS
Net Income
-62m ILS
Fundamental Scores

INCR Profitability Score
Profitability Due Diligence

InterCure Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive Revenue Growth Forecast
Declining ROIC
50/100
Profitability
Score

InterCure Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

INCR Solvency Score
Solvency Due Diligence

InterCure Ltd's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
44/100
Solvency
Score

InterCure Ltd's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INCR Price Targets Summary
InterCure Ltd

There are no price targets for INCR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

InterCure Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for INCR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one INCR stock?

The intrinsic value of one INCR stock under the Base Case scenario is 1 680.11 ILS.

Is INCR stock undervalued or overvalued?

Compared to the current market price of 556.2 ILS, InterCure Ltd is Undervalued by 67%.

Back to Top